Barker Margo E, McCloskey Eugene, Saha Shikha, Gossiel Fatma, Charlesworth Diane, Powers Hilary J, Blumsohn Aubrey
Human Nutrition Unit, Division of Clinical Sciences (North), University of Sheffield, United Kingdom.
J Bone Miner Res. 2005 Jun;20(6):913-20. doi: 10.1359/JBMR.050112. Epub 2005 Jan 24.
There is debate about the possible deleterious effect of excessive vitamin A exposure on fracture risk. In this nested case control study in older women (312 cases and 934 controls), serum retinol, retinyl palmitate, and beta-carotene were not associated with fracture risk, and there was no evidence of excess risk with multivitamin or cod liver oil supplementation.
Recent studies have suggested that higher vitamin A intake may account for a component of fracture risk within the general population and that supplemental vitamin A may be harmful even within recommended limits. No studies have examined the relationship between biochemical retinol status and fracture in older women.
We examined serum retinol, retinyl palmitate, and beta-carotene as predictors of incident hip and other fractures in a large prospective study of British women over the age of 75 years (n = 2606, 312 incident osteoporotic fractures, 92 incident hip fractures; mean follow-up duration, 3.7 years). Fasting blood samples (9:00-11:00 a.m.) were collected at baseline. Using a case-control design (three controls per case), serum retinol, retinyl palmitate, and beta-carotene were assessed as univariate predictors of incident osteoporotic fracture or hip fracture. Baseline BMD at the total hip, age, 25(OH)D, serum beta Crosslaps, bone-specific alkaline phosphatase, weight, height, and smoking were considered as covariates in a multivariate model.
Serum retinol, retinyl palmitate, and beta-carotene were not significant univariate predictors of either hip fracture or any fracture (all p > 0.05; Cox proportional hazards regression). For all osteoporotic fractures, the hazard ratio (HR) was 0.92 (95% CI, 0.81-1.05) per 1 SD increase in serum retinol. Risk of any osteoporotic fracture was slightly less in the highest quartile of serum retinol compared with the lowest quartile (HR, 0.85; 95% CI, 0.69-1.05; p = 0.132) There was a tendency for increased serum retinol to predict benefit rather than harm in terms of BMD (r = 0.09, p = 0.002). Multivitamin or cod liver oil supplementation was associated with a significantly lower risk of any fracture (HR, 0.76; 95% CI, 0.60-0.96; p = 0.021). In multivariate analysis, only age, total hip BMD, and weight were associated with fracture risk (p < 0.05).
We found no evidence to support any skeletal harm associated with increased serum indices of retinol exposure or modest retinol supplementation in this population.
关于过量摄入维生素A对骨折风险可能产生的有害影响存在争议。在这项针对老年女性的巢式病例对照研究中(312例病例和934例对照),血清视黄醇、棕榈酸视黄酯和β-胡萝卜素与骨折风险无关,并且没有证据表明补充多种维生素或鱼肝油会增加风险。
最近的研究表明,较高的维生素A摄入量可能是普通人群骨折风险的一个因素,并且即使在推荐剂量范围内,补充维生素A也可能有害。尚无研究探讨老年女性生化视黄醇水平与骨折之间的关系。
在一项针对75岁以上英国女性的大型前瞻性研究中(n = 2606,312例骨质疏松性骨折,92例髋部骨折;平均随访时间3.7年),我们检测了血清视黄醇、棕榈酸视黄酯和β-胡萝卜素,以预测髋部及其他骨折的发生情况。在基线时采集上午9:00 - 11:00的空腹血样。采用病例对照设计(每个病例3个对照),将血清视黄醇、棕榈酸视黄酯和β-胡萝卜素作为骨质疏松性骨折或髋部骨折发生的单变量预测指标。全髋部基线骨密度、年龄、25(OH)D、血清β-交联羧基末端肽、骨特异性碱性磷酸酶、体重、身高和吸烟情况在多变量模型中被视为协变量。
血清视黄醇、棕榈酸视黄酯和β-胡萝卜素均不是髋部骨折或任何骨折的显著单变量预测指标(所有p > 0.05;Cox比例风险回归)。对于所有骨质疏松性骨折,血清视黄醇每增加1个标准差,风险比(HR)为0.92(95%可信区间,0.81 - 1.05)。血清视黄醇最高四分位数组的任何骨质疏松性骨折风险略低于最低四分位数组(HR,0.85;95%可信区间,0.69 - 1.05;p = 0.132)。就骨密度而言,血清视黄醇升高有预测益处而非危害的趋势(r = 0.09,p = 0.002)。补充多种维生素或鱼肝油与任何骨折风险显著降低相关(HR,0.76;95%可信区间,0.60 - 0.96;p = 0.021)。在多变量分析中,只有年龄、全髋部骨密度和体重与骨折风险相关(p < 0.05)。
我们没有发现证据支持在该人群中,血清视黄醇暴露指标升高或适度补充视黄醇会对骨骼造成任何损害。